Dashboard
Manage Tickers

ABVXAbivax S.A.

Nasdaq www.abivax.com


$ 13.43 $ 0.47 (3.69 %)    

Friday, 28-Jun-2024 15:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.98 $ -2.50 (-0.52 %)
DIA $ 391.11 $ -0.43 (-0.11 %)
SPY $ 544.70 $ -2.15 (-0.39 %)
TLT $ 91.77 $ -1.74 (-1.86 %)
GLD $ 215.03 $ 0.02 (0.01 %)
$ 13.22
$ 12.51
$ 0.00 x 0
$ 13.49 x 100
$ 12.48 - $ 13.47
$ 8.00 - $ 17.02
59,620
na
569.33M
$ 0.41
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

amc-networks-louisiana-pacific-and-other-big-stocks-moving-lower-in-mondays-pre-market-session
AMC Networks, Louisiana-Pacific And Other ...
06/17/2024 11:41:51

btig-initiates-coverage-on-abivax-with-buy-rating-announces-price-target-of-43
BTIG Initiates Coverage On Abivax with Buy...
05/20/2024 11:36:19

BTIG analyst Julian Harrison initiates coverage on Abivax (NASDAQ:ABVX) with a Buy rating and announces Price Target of $43.

abivax-to-present-four-abstracts-for-obefazimod-in-ulcerative-colitis-and-preclinical-colon-cancer-model-at-digestive-disease-week-2024
Abivax To Present Four Abstracts For Obefa...
05/08/2024 08:18:39

"With four abstracts accepted for presentation at DDW 2024, we look forward to our continued exchange with the IBD communit...

abivax-shares-are-trading-higher-after-guggenheim-and-piper-sandler-initiated-coverage-on-the-stock-with-bullish-ratings
Abivax shares are trading higher after Gug...
04/29/2024 11:38:54

guggenheim-initiates-coverage-on-abivax-with-buy-rating-announces-price-target-of-50
Guggenheim Initiates Coverage On Abivax wi...
04/29/2024 10:22:22

Guggenheim analyst Yatin Suneja initiates coverage on Abivax (NASDAQ:ABVX) with a Buy rating and announces Price Target of $50.

piper-sandler-initiates-coverage-on-abivax-with-overweight-rating-announces-price-target-of-42
Piper Sandler Initiates Coverage On Abivax...
04/29/2024 09:39:20

Piper Sandler analyst Christopher Raymond initiates coverage on Abivax (NASDAQ:ABVX) with a Overweight rating and announces ...

morgan-stanley-maintains-equal-weight-on-abivax-raises-price-target-to-16
Morgan Stanley Maintains Equal-Weight on A...
04/11/2024 11:29:01

Morgan Stanley analyst Vikram Purohit maintains Abivax (NASDAQ:ABVX) with a Equal-Weight and raises the price target from $1...

earnings-scheduled-for-april-2-2024
Earnings Scheduled For April 2, 2024
04/02/2024 10:25:53

Companies Reporting Before The Bell • Ocugen (NASDAQ:OCGN) is estimated to report earnings for its fourth quarter.

abivax-fy23-net-loss-1474m-down-from-607m-yoy-cash-position-261m
Abivax FY23 Net Loss €(147.4)M Down From €...
04/02/2024 08:06:52

abivax-announces-modifications-to-its-phase-2-development-program-of-obefazimod-in-crohns-disease-to-align-with-recent-fda-feedback
Abivax Announces Modifications To Its Phas...
02/02/2024 07:55:06

Abivax announces update to obefazimod Phase 2b clinical development program in moderately to severely active Crohn's diseas...

abivax-to-host-kol-investor-event-to-review-phase-2b-data-and-phase-3-trial-design-for-obefazimod-in-patients-with-moderately-to-severely-active-ulcerative-colitis-on-february-6
Abivax To Host KOL Investor Event To Revie...
01/24/2024 10:36:54

abivax-sets-2024-strategic-vision-with-major-milestones-prioritizes-completion-of-patient-recruitment-into-the-abtect-phase-3-induction-trials
Abivax Sets 2024 Strategic Vision with Maj...
01/22/2024 07:49:46

Abivax provides 2024 strategic outlook and lays out key milestones over next 12 months Induction data read-out expected Q1 2...

leerink-partners-initiates-coverage-on-abivax-with-outperform-rating-announces-price-target-of-20
Leerink Partners Initiates Coverage On Abi...
11/14/2023 13:11:38

Leerink Partners analyst Thomas Smith initiates coverage on Abivax (NASDAQ:ABVX) with a Outperform rating and announces Pric...

morgan-stanley-initiates-coverage-on-abivax-with-equal-weight-rating-announces-price-target-of-15
Morgan Stanley Initiates Coverage On Abiva...
11/14/2023 13:09:45

Morgan Stanley analyst Vikram Purohit initiates coverage on Abivax (NASDAQ:ABVX) with a Equal-Weight rating and announces Pr...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)